Christopher Rovaldi

KROS

Christopher Rovaldi serves as Chief Operating Officer at Keros Therapeutics, Inc. (KROS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$162.0K

Net Position

Net Seller

$162.0K

Companies Traded

KROS

Active Period

Apr 2022

2 total trades

Most Recent

Sell KROS

Apr 8, 2022 · $112.3K

Christopher Rovaldi's Insider Trading at Keros Therapeutics, Inc. (KROS)

Buys

0 · $0.00

Sells

2 · $162.0K

Total Shares Bought

Total Shares Sold

2,592

KROS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 8, 2022	Sell	1,728	$65.00	$112.3K	0
Apr 5, 2022	Sell	864	$57.49	$49.7K	862

Related Insiders

BIENAIME JEAN JACQUES

director

KROSBuy · Apr 17, 2026

Jasbir Seehra

CHIEF EXECUTIVE OFFICER

KROSSell · Feb 19, 2026

Lorena Raquel Lerner

Chief Science Officer

KROSSell · Feb 18, 2026

Esther Cho

SVP, General Counsel

KROSSell · Feb 18, 2026

Keith Regnante

CHIEF FINANCIAL OFFICER

KROSSell · Feb 18, 2026

Pontifax Management 4 G.P. (2015) Ltd.

10% Owner

KROSSell · Oct 17, 2025

ADAR1 Capital Management, LLC

10% Owner

KROSSell · Oct 15, 2025

Explore More Insider Trading Data

KROS Insider Trading Activity

View all insider trades at Keros Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity